Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

FACTOR THERAPEUTICS LIMITED

INVESTOR PRESENTATION - FACTOR THERAPEUTICS LIMITED

ASX:FTT

FACTOR THERAPEUTICS LIMITED

Health Care

Factor Therapeutics Limited (FTT, formerly Tissue Therapies Limited) is an Australian biomedical technology company which develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. FTT is commercialising VF-001, a technology for cell based therapies. FTT is also developing treatments for psoriasis, scar prevention and various cancers including those of the breast, colon and prostate. Former Names Tissue Therapies Limited (TIS), 04/05/2016

Read more

Market Cap

5.21m

Price at Close

$0.005

4w avg. Volume

0.00

4w avg. Turnover

$0.00

Announcements
announcementt+2 movementdate
  • Appendix 3Z - Final Director's Interest Notice

    Shareholder Details

  • 0.00%

    31 Jul 2020

0.00%

31 Jul 2020
  • AGM - Results of Meeting

    Notice Of Meeting

  • 0.00%

    30 Jul 2020

0.00%

30 Jul 2020
  • Chair Address to AGM and LONGMILE presentation

    Periodic Reports · Market sensitive

  • 0.00%

    29 Jul 2020

0.00%

29 Jul 2020
  • Appendix 4D and Report for half-year to 30 June 2020

    Periodic Reports · Market sensitive

  • 0.00%

    29 Jul 2020

0.00%

29 Jul 2020
  • Continued Suspension from Official Quotation

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    24 Jul 2020

0.00%

24 Jul 2020
  • Change to Board composition

    Company Administration · Market sensitive

  • 0.00%

    23 Jul 2020

0.00%

23 Jul 2020
  • FTT enters agreement- Veterinary Medical Technology Pipeline

    Progress Report · Market sensitive

  • 0.00%

    23 Jul 2020

0.00%

23 Jul 2020
  • Appendix 4C and Activities Report - June 2020 Quarter

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    22 Jul 2020

0.00%

22 Jul 2020
  • Suspension from Official Quotation

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    16 Jul 2020

0.00%

16 Jul 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    15 Jul 2020

0.00%

15 Jul 2020
Market Data

Current Price

$0.005

52WK HIGH

$0.007

52WK LOW

$0.001

1YR RETURN

+25.00%

1YR RETURN VS. SECTOR

-1.73%

90 DAY RETURN

0.00%

ASX RANK

1,871

/2,008

SECTOR RANK

47

/47

SHARES OUTSTANDING

1.04b
ASX:FTT

FACTOR THERAPEUTICS LIMITED

Health Care

Factor Therapeutics Limited (FTT, formerly Tissue Therapies Limited) is an Australian biomedical technology company which develops treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. FTT is commercialising VF-001, a technology for cell based therapies. FTT is also developing treatments for psoriasis, scar prevention and various cancers including those of the breast, colon and prostate. Former Names Tissue Therapies Limited (TIS), 04/05/2016

Read more

Market Cap

5.21m

Price at Close

$0.005

4w avg. Volume

0.00

4w avg. Turnover

$0.00

ASX:FTT is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.